185 related articles for article (PubMed ID: 30867554)
1. Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.
Papadopoulou A; Alvanou M; Koukoulias K; Athanasiou E; Lazaridou A; Savvopoulos N; Kaloyannidis P; Markantonatou AM; Vyzantiadis TA; Yiangou M; Anagnostopoulos A; Yannaki E
Bone Marrow Transplant; 2019 Dec; 54(12):1963-1972. PubMed ID: 30867554
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.
Tischer-Zimmermann S; Salzer E; Bitencourt T; Frank N; Hoffmann-Freimüller C; Stemberger J; Maecker-Kolhoff B; Blasczyk R; Witt V; Fritsch G; Paster W; Lion T; Eiz-Vesper B; Geyeregger R
Front Immunol; 2023; 14():988947. PubMed ID: 37090716
[TBL] [Abstract][Full Text] [Related]
3. Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus.
Gaundar SS; Clancy L; Blyth E; Meyer W; Gottlieb DJ
Cytotherapy; 2012 Oct; 14(9):1119-30. PubMed ID: 22866666
[TBL] [Abstract][Full Text] [Related]
4. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus.
Beck O; Topp MS; Koehl U; Roilides E; Simitsopoulou M; Hanisch M; Sarfati J; Latgé JP; Klingebiel T; Einsele H; Lehrnbecher T
Blood; 2006 Mar; 107(6):2562-9. PubMed ID: 16322466
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges.
Papadopoulou A; Kaloyannidis P; Yannaki E; Cruz CR
Crit Rev Oncol Hematol; 2016 Feb; 98():62-72. PubMed ID: 26527379
[TBL] [Abstract][Full Text] [Related]
6. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.
Tramsen L; Schmidt S; Boenig H; Latgé JP; Lass-Flörl C; Roeger F; Seifried E; Klingebiel T; Lehrnbecher T
Cytotherapy; 2013 Mar; 15(3):344-51. PubMed ID: 23579059
[TBL] [Abstract][Full Text] [Related]
7. Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.
Bacher P; Jochheim-Richter A; Mockel-Tenbrink N; Kniemeyer O; Wingenfeld E; Alex R; Ortigao A; Karpova D; Lehrnbecher T; Ullmann AJ; Hamprecht A; Cornely O; Brakhage AA; Assenmacher M; Bonig H; Scheffold A
Cytotherapy; 2015 Oct; 17(10):1396-405. PubMed ID: 26188965
[TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.
Ramadan G; Davies B; Kurup VP; Keever-Taylor CA
Clin Exp Immunol; 2005 Apr; 140(1):81-91. PubMed ID: 15762878
[TBL] [Abstract][Full Text] [Related]
9. CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to
Page L; Wallstabe J; Lother J; Bauser M; Kniemeyer O; Strobel L; Voltersen V; Teutschbein J; Hortschansky P; Morton CO; Brakhage AA; Topp M; Einsele H; Wurster S; Loeffler J
Front Immunol; 2021; 12():659752. PubMed ID: 34122417
[No Abstract] [Full Text] [Related]
10. Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection.
Sun Z; Zhu P; Li L; Wan Z; Zhao Z; Li R
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3089-96. PubMed ID: 22696051
[TBL] [Abstract][Full Text] [Related]
11. Cultivated anti-Aspergillus T(H)1 cells.
Lehrnbecher T; Beck O; Koehl U; Tramsen L
Med Mycol; 2009; 47 Suppl 1():S170-4. PubMed ID: 18651313
[TBL] [Abstract][Full Text] [Related]
12. Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.
Stuehler C; Kuenzli E; Jaeger VK; Baettig V; Ferracin F; Rajacic Z; Kaiser D; Bernardini C; Forrer P; Weisser M; Elzi L; Battegay M; Halter J; Passweg J; Khanna N
J Infect Dis; 2015 Sep; 212(6):959-67. PubMed ID: 25748323
[TBL] [Abstract][Full Text] [Related]
13. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.
Tramsen L; Koehl U; Tonn T; Latgé JP; Schuster FR; Borkhardt A; Uharek L; Quaritsch R; Beck O; Seifried E; Klingebiel T; Lehrnbecher T
Bone Marrow Transplant; 2009 Jan; 43(1):13-9. PubMed ID: 18762764
[TBL] [Abstract][Full Text] [Related]
14. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
[TBL] [Abstract][Full Text] [Related]
15. [Invasive fungal infections in immunocompromised patients with focus on aspergillosis and its causative agents].
Paloušová D; Lengerová M; Volfová P; Bejdák P; Kocmanová I; Mayer J; Ráčil Z
Klin Mikrobiol Infekc Lek; 2012 Aug; 18(4):96-101. PubMed ID: 23172020
[TBL] [Abstract][Full Text] [Related]
16. Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen.
Ramadan G; Davies B; Kurup VP; Keever-Taylor CA
Clin Exp Immunol; 2005 Feb; 139(2):257-67. PubMed ID: 15654824
[TBL] [Abstract][Full Text] [Related]
17. Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients.
Potenza L; Vallerini D; Barozzi P; Riva G; Forghieri F; Beauvais A; Beau R; Candoni A; Maertens J; Rossi G; Morselli M; Zanetti E; Quadrelli C; Codeluppi M; Guaraldi G; Pagano L; Caira M; Del Giovane C; Maccaferri M; Stefani A; Morandi U; Tazzioli G; Girardis M; Delia M; Specchia G; Longo G; Marasca R; Narni F; Merli F; Imovilli A; Apolone G; Carvalho A; Comoli P; Romani L; Latgè JP; Luppi M
PLoS One; 2013; 8(9):e74326. PubMed ID: 24023936
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
[TBL] [Abstract][Full Text] [Related]
19. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections.
Stuehler C; Nowakowska J; Bernardini C; Topp MS; Battegay M; Passweg J; Khanna N
J Infect Dis; 2015 Apr; 211(8):1251-61. PubMed ID: 25367298
[TBL] [Abstract][Full Text] [Related]
20. CD4
Diaz-Arevalo D; Kalkum M
Methods Mol Biol; 2017; 1625():281-293. PubMed ID: 28584997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
